Alex Delaney-Gesing, Senior Editor

The amount of light effused by these round-shaped eyeglass frames are designed to match the exact wavelength of sunlight a user would be exposed to outside.

The company, formerly known as Clover Therapeutics, intends to use the funding to advance two lead drug candidates that target molecularly-defined AMD patient subtypes.

Maria Sampalis, OD, continues her dry eye discussion by sharing what factors she considers when diagnosing and treating patients.

Companies are entering an exclusive licensing agreement for the development and commercialization of Brimochol PF and Carbachol PF in three new regions: Greater China, South Korea, and select Southeast Asian territories.

The company's technology allows for ECPs to detect, monitor, and treat AMD 3 years before clinical diagnosis.

Researchers are investigating a 3D-printed self-moisturizing contact lens that could be a catalyst for the development of next-generation contact lens-based medical devices.